Maze Therapeutics said on Thursday that it raised $140 million in an initial public offering, setting the stage for a debut that could make the kidney disease drug developer the first U.S. biotech ...

Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed biotech company ...

Meta Platforms and Tesla helped lead most U.S. stocks higher following a rush of profit reports from some of the country’s most influential companies. The S&P 500 climbed 0.5% Thursday. The Dow Jones ...

In a briefing that recalled his most extreme first term remarks, President Trump said without any evidence that diversity ...

The average rate on a 30-year mortgage in the U.S. eased for the second week in a row, but remains just below 7%, little ...

The extent of the impacts of the Trump administration’s sudden 90-day freeze of almost all foreign aid is still unclear ...

In the three years before the deadly collision between an Army helicopter and an American Airlines flight near Reagan ...

Growth slowed but remained resilient at the end of 2024, leaving the US economy on solid footing heading into a new year — ...

Wall Street ended up on relief Meta and Microsoft kept their AI spending plans even amid mixed earnings. Next up, Apple earnings.

The Old Farmer's Almanac, which has been in business since 1792, recently released its spring weather forecast. The outlook? ...

Tulsi Gabbard is expected to face tough questions from lawmakers Thursday over past comments about Russia and a 2017 visit ...

From Russia with love — of knowledge. A Long Island student who came to Mastic Beach as a child while knowing very little of ...